Follow The Filings

Catalyst Pharmaceuticals Inc.

Health Care, filed as CATALYST PHARMACEUTICALS INC (COM), Equity As of 2026 Q2 among managers we track

  • 2 Owners
  • Max 1.1%
  • $17M
  • 1 new 1 exit

In 2026 Q2 George Soros opened a position in Catalyst Pharmaceuticals, while Terry Smith sold out.

Who owns this now

Largest portfolio weights among holders, up to 1.1% (Third Avenue Management). Not free-float ownership.

  1. Third Avenue Management 1.1%
  2. George Soros New 0.13%

Holders

Sorted by value, long equity only, as of 2026 Q2.

History
George Soros, Soros Fund Management 0.13% New 0.13% 344,593 $11M History
Third Avenue Management 1.1% Hold 210,161 $6.6M History
Terry Smith, Fundsmith exited 2026 Q2 Last 2026 Q1 0.16% Exit −0.16% 844,887 $21M History

2 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.